PRICE T ROWE ASSOCIATES INC /MD/ - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 40 filers reported holding LUMOS PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q4 2022$361
-100.0%
100,000
-11.2%
0.00%
Q3 2022$997,000
+1.1%
112,576
-12.0%
0.00%
Q2 2022$986,000
-34.6%
127,994
-19.8%
0.00%
Q1 2022$1,508,000
+36.1%
159,5950.0%0.00%
Q4 2021$1,108,000
-27.0%
159,5950.0%0.00%
Q3 2021$1,518,000
-4.3%
159,5950.0%0.00%
Q2 2021$1,586,000159,5950.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Acuitas Investments, LLC 125,242$413,2990.24%
Lion Point Capital, LP 90,794$299,6200.13%
Greenwich Wealth Management LLC 76,341$2520.03%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 25,760$85,0080.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
Leucadia National 120,651$398,1480.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders